Ten things you should know about protein kinases: IUPHAR Review 14

作者: Doriano Fabbro , Sandra W Cowan-Jacob , Henrik Moebitz

DOI: 10.1111/BPH.13096

关键词:

摘要: Many human malignancies are associated with aberrant regulation of protein or lipid kinases due to mutations, chromosomal rearrangements and/or gene amplification. Protein and represent an important target class for treating disorders. This review focus on ‘the 10 things you should know about their inhibitors', including a short introduction the history inhibitors ending perspective kinase drug discovery. Although ‘10 things’ have been, certain extent, chosen arbitrarily, they cover in comprehensive way past present efforts discovery summarize status quo current as well knowledge structure binding modes. Besides describing potentials drugs, this also limitations, particularly how circumvent emerging resistance against oncological indications.

参考文章(294)
D. Fabbro, G. Fendrich, V. Guez, T. Meyer, P. Furet, J. Mestan, J. D. Griffin, P. W. Manley, S. W. Cowan-Jacob, Targeted Therapy with Imatinib: An Exception or a Rule? Inhibitors of Protein Kinases and Protein Phosphates. ,vol. 167, pp. 361- 389 ,(2005) , 10.1007/3-540-26670-4_13
Philipp le Coutre, Elena Tassi, Marileila Varella-Garcia, Rossella Barni, Luca Mologni, Gonçalo Cabrita, Edoardo Marchesi, Rosanna Supino, Carlo Gambacorti-Passerini, Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification. Blood. ,vol. 95, pp. 1758- 1766 ,(2000) , 10.1182/BLOOD.V95.5.1758.005A41_1758_1766
Antonio Jimeno, Rodabe N Amaria, T. Medina, Dabrafenib in the treatment of advanced melanoma. Drugs of Today. ,vol. 49, pp. 377- 385 ,(2013) , 10.1358/DOT.2013.49.6.1968669
Y Suzuki, M Shibuya, Treatment of cerebral vasospasm by a protein kinase inhibitor AT 877 Nō to shinkei Brain and nerve. ,vol. 45, pp. 819- 824 ,(1993)
Alan Berezov, Natalie Minkovsky, BIBW-2992, a dual receptor tyrosine kinase inhibitor for the treatment of solid tumors. Current opinion in investigational drugs. ,vol. 9, pp. 1336- ,(2008)
Doriano Fabbro, Sandra W. Cowan-Jacob, Henrik Möbitz, Georg Martiny-Baron, Targeting cancer with small-molecular-weight kinase inhibitors. Methods of Molecular Biology. ,vol. 795, pp. 1- 34 ,(2012) , 10.1007/978-1-61779-337-0_1
Nick J. Dibb, Stephen M. Dilworth, Clifford D. Mol, Switching on kinases: oncogenic activation of BRAF and the PDGFR family. Nature Reviews Cancer. ,vol. 4, pp. 718- 727 ,(2004) , 10.1038/NRC1434
Bernhard Schmierer, Caroline S. Hill, TGFβ–SMAD signal transduction: molecular specificity and functional flexibility Nature Reviews Molecular Cell Biology. ,vol. 8, pp. 970- 982 ,(2007) , 10.1038/NRM2297